When norms normalize : The case of genetic enhancement
As the possibility of genetic intervention becomes more concrete, defining and regulating ethically permissible interventions must include a consideration of the implicit as well as explicit consequences. These include the moral implications of defining "enhancement" by reference to a stan...
Gespeichert in:
Veröffentlicht in: | Human gene therapy 2001, Vol.12 (1), p.87-95 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 95 |
---|---|
container_issue | 1 |
container_start_page | 87 |
container_title | Human gene therapy |
container_volume | 12 |
creator | SCULLY, Jackie Leach REHMANN-SUTTER, Christoph |
description | As the possibility of genetic intervention becomes more concrete, defining and regulating ethically permissible interventions must include a consideration of the implicit as well as explicit consequences. These include the moral implications of defining "enhancement" by reference to a standard of normality. Some authors have called into question the standard ethical concerns about genetic enhancement, but the distinction between enhancing and therapeutic interventions is still structured as relatively unproblematic. However, determining the boundary between therapy and enhancement will have feedback effects on the socially implemented definitions of what counts as normal in human embodiment. Positioning the interface between permissible and nonpermissible interventions at the same place as the boundaries between therapy and enhancement, and between normal and abnormal embodiment, (1) uses biology to justify a moral evaluation, (2) privileges the single standpoint of the genetically canonical person, and (3) enhances the dichotomy between "normal" and "not normal". Assuming that the limit of permissibility along the interventional continuum is coterminous with the definitions of enhancement and of normality, distracts from the work of uncovering the real grounds to setting limits to genetic manipulation. |
doi_str_mv | 10.1089/104303401451004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70619545</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17772035</sourcerecordid><originalsourceid>FETCH-LOGICAL-c352t-9a5f80fd575dc2c96bf5362bb8e159af3abd5051184ad6d99c2f61ce2e6edf4d3</originalsourceid><addsrcrecordid>eNqFkMtLw0AQhxdRrFbP3iQgeIvd2WfWmxRfUPBS8Rg2m1kbyaNm04P-9W5tUPDiZWZgvvnBfIScAb0CmpkZUMEpFxSEBErFHjkCKXWqBWP7cY7bNK7ZhByH8EYpcKn0IZkAgNZSqCOiXlbYJm3XN-G72rr6xOQ6Wa4wcTZg0vnkFVscKpdgu7Ktwwbb4YQceFsHPB37lDzf3S7nD-ni6f5xfrNIHZdsSI2VPqO-lFqWjjmjCi-5YkWRIUhjPbdFKakEyIQtVWmMY16BQ4YKSy9KPiWXu9x1371vMAx5UwWHdW1b7DYh11SBkUL-C8Z_NaN8C852oOu7EHr0-bqvGtt_5EDzrdP8j9N4cT5Gb4oGy19-lBiBixGwwdna99FSFX44E1Myw78AuUt8MQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17772035</pqid></control><display><type>article</type><title>When norms normalize : The case of genetic enhancement</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>SCULLY, Jackie Leach ; REHMANN-SUTTER, Christoph</creator><creatorcontrib>SCULLY, Jackie Leach ; REHMANN-SUTTER, Christoph</creatorcontrib><description>As the possibility of genetic intervention becomes more concrete, defining and regulating ethically permissible interventions must include a consideration of the implicit as well as explicit consequences. These include the moral implications of defining "enhancement" by reference to a standard of normality. Some authors have called into question the standard ethical concerns about genetic enhancement, but the distinction between enhancing and therapeutic interventions is still structured as relatively unproblematic. However, determining the boundary between therapy and enhancement will have feedback effects on the socially implemented definitions of what counts as normal in human embodiment. Positioning the interface between permissible and nonpermissible interventions at the same place as the boundaries between therapy and enhancement, and between normal and abnormal embodiment, (1) uses biology to justify a moral evaluation, (2) privileges the single standpoint of the genetically canonical person, and (3) enhances the dichotomy between "normal" and "not normal". Assuming that the limit of permissibility along the interventional continuum is coterminous with the definitions of enhancement and of normality, distracts from the work of uncovering the real grounds to setting limits to genetic manipulation.</description><identifier>ISSN: 1043-0342</identifier><identifier>EISSN: 1557-7422</identifier><identifier>DOI: 10.1089/104303401451004</identifier><identifier>PMID: 11177546</identifier><identifier>CODEN: HGTHE3</identifier><language>eng</language><publisher>Larchmont, NY: Liebert</publisher><subject>Bioethics ; Biological and medical sciences ; Biotechnology ; Ethics, Medical ; Fundamental and applied biological sciences. Psychology ; Gene therapy ; Genetic Engineering - legislation & jurisprudence ; Genetic Enhancement ; Genetic Therapy - legislation & jurisprudence ; Health. Pharmaceutical industry ; Human Experimentation ; Humans ; Industrial applications and implications. Economical aspects ; Medical Laboratory Science - legislation & jurisprudence</subject><ispartof>Human gene therapy, 2001, Vol.12 (1), p.87-95</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c352t-9a5f80fd575dc2c96bf5362bb8e159af3abd5051184ad6d99c2f61ce2e6edf4d3</citedby><cites>FETCH-LOGICAL-c352t-9a5f80fd575dc2c96bf5362bb8e159af3abd5051184ad6d99c2f61ce2e6edf4d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3042,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=910089$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11177546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SCULLY, Jackie Leach</creatorcontrib><creatorcontrib>REHMANN-SUTTER, Christoph</creatorcontrib><title>When norms normalize : The case of genetic enhancement</title><title>Human gene therapy</title><addtitle>Hum Gene Ther</addtitle><description>As the possibility of genetic intervention becomes more concrete, defining and regulating ethically permissible interventions must include a consideration of the implicit as well as explicit consequences. These include the moral implications of defining "enhancement" by reference to a standard of normality. Some authors have called into question the standard ethical concerns about genetic enhancement, but the distinction between enhancing and therapeutic interventions is still structured as relatively unproblematic. However, determining the boundary between therapy and enhancement will have feedback effects on the socially implemented definitions of what counts as normal in human embodiment. Positioning the interface between permissible and nonpermissible interventions at the same place as the boundaries between therapy and enhancement, and between normal and abnormal embodiment, (1) uses biology to justify a moral evaluation, (2) privileges the single standpoint of the genetically canonical person, and (3) enhances the dichotomy between "normal" and "not normal". Assuming that the limit of permissibility along the interventional continuum is coterminous with the definitions of enhancement and of normality, distracts from the work of uncovering the real grounds to setting limits to genetic manipulation.</description><subject>Bioethics</subject><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Ethics, Medical</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene therapy</subject><subject>Genetic Engineering - legislation & jurisprudence</subject><subject>Genetic Enhancement</subject><subject>Genetic Therapy - legislation & jurisprudence</subject><subject>Health. Pharmaceutical industry</subject><subject>Human Experimentation</subject><subject>Humans</subject><subject>Industrial applications and implications. Economical aspects</subject><subject>Medical Laboratory Science - legislation & jurisprudence</subject><issn>1043-0342</issn><issn>1557-7422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtLw0AQhxdRrFbP3iQgeIvd2WfWmxRfUPBS8Rg2m1kbyaNm04P-9W5tUPDiZWZgvvnBfIScAb0CmpkZUMEpFxSEBErFHjkCKXWqBWP7cY7bNK7ZhByH8EYpcKn0IZkAgNZSqCOiXlbYJm3XN-G72rr6xOQ6Wa4wcTZg0vnkFVscKpdgu7Ktwwbb4YQceFsHPB37lDzf3S7nD-ni6f5xfrNIHZdsSI2VPqO-lFqWjjmjCi-5YkWRIUhjPbdFKakEyIQtVWmMY16BQ4YKSy9KPiWXu9x1371vMAx5UwWHdW1b7DYh11SBkUL-C8Z_NaN8C852oOu7EHr0-bqvGtt_5EDzrdP8j9N4cT5Gb4oGy19-lBiBixGwwdna99FSFX44E1Myw78AuUt8MQ</recordid><startdate>2001</startdate><enddate>2001</enddate><creator>SCULLY, Jackie Leach</creator><creator>REHMANN-SUTTER, Christoph</creator><general>Liebert</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>2001</creationdate><title>When norms normalize : The case of genetic enhancement</title><author>SCULLY, Jackie Leach ; REHMANN-SUTTER, Christoph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c352t-9a5f80fd575dc2c96bf5362bb8e159af3abd5051184ad6d99c2f61ce2e6edf4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Bioethics</topic><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Ethics, Medical</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene therapy</topic><topic>Genetic Engineering - legislation & jurisprudence</topic><topic>Genetic Enhancement</topic><topic>Genetic Therapy - legislation & jurisprudence</topic><topic>Health. Pharmaceutical industry</topic><topic>Human Experimentation</topic><topic>Humans</topic><topic>Industrial applications and implications. Economical aspects</topic><topic>Medical Laboratory Science - legislation & jurisprudence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SCULLY, Jackie Leach</creatorcontrib><creatorcontrib>REHMANN-SUTTER, Christoph</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Human gene therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SCULLY, Jackie Leach</au><au>REHMANN-SUTTER, Christoph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>When norms normalize : The case of genetic enhancement</atitle><jtitle>Human gene therapy</jtitle><addtitle>Hum Gene Ther</addtitle><date>2001</date><risdate>2001</risdate><volume>12</volume><issue>1</issue><spage>87</spage><epage>95</epage><pages>87-95</pages><issn>1043-0342</issn><eissn>1557-7422</eissn><coden>HGTHE3</coden><abstract>As the possibility of genetic intervention becomes more concrete, defining and regulating ethically permissible interventions must include a consideration of the implicit as well as explicit consequences. These include the moral implications of defining "enhancement" by reference to a standard of normality. Some authors have called into question the standard ethical concerns about genetic enhancement, but the distinction between enhancing and therapeutic interventions is still structured as relatively unproblematic. However, determining the boundary between therapy and enhancement will have feedback effects on the socially implemented definitions of what counts as normal in human embodiment. Positioning the interface between permissible and nonpermissible interventions at the same place as the boundaries between therapy and enhancement, and between normal and abnormal embodiment, (1) uses biology to justify a moral evaluation, (2) privileges the single standpoint of the genetically canonical person, and (3) enhances the dichotomy between "normal" and "not normal". Assuming that the limit of permissibility along the interventional continuum is coterminous with the definitions of enhancement and of normality, distracts from the work of uncovering the real grounds to setting limits to genetic manipulation.</abstract><cop>Larchmont, NY</cop><pub>Liebert</pub><pmid>11177546</pmid><doi>10.1089/104303401451004</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1043-0342 |
ispartof | Human gene therapy, 2001, Vol.12 (1), p.87-95 |
issn | 1043-0342 1557-7422 |
language | eng |
recordid | cdi_proquest_miscellaneous_70619545 |
source | Mary Ann Liebert Online Subscription; MEDLINE |
subjects | Bioethics Biological and medical sciences Biotechnology Ethics, Medical Fundamental and applied biological sciences. Psychology Gene therapy Genetic Engineering - legislation & jurisprudence Genetic Enhancement Genetic Therapy - legislation & jurisprudence Health. Pharmaceutical industry Human Experimentation Humans Industrial applications and implications. Economical aspects Medical Laboratory Science - legislation & jurisprudence |
title | When norms normalize : The case of genetic enhancement |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T14%3A54%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=When%20norms%20normalize%20:%20The%20case%20of%20genetic%20enhancement&rft.jtitle=Human%20gene%20therapy&rft.au=SCULLY,%20Jackie%20Leach&rft.date=2001&rft.volume=12&rft.issue=1&rft.spage=87&rft.epage=95&rft.pages=87-95&rft.issn=1043-0342&rft.eissn=1557-7422&rft.coden=HGTHE3&rft_id=info:doi/10.1089/104303401451004&rft_dat=%3Cproquest_cross%3E17772035%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17772035&rft_id=info:pmid/11177546&rfr_iscdi=true |